March 14, 2023 02:19 PM EDT

Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week

Zachary Brennan

Senior Editor

Ahead of Thursday’s meeting of the FDA’s Antimicrobial Drugs Advisory Committee, which will decide whether to flip Pfizer’s blockbuster Covid-19 pill from an EUA to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Pharma's wins and losses in Trump's sprawling executive order on drug prices

In a blow to its obesity pipeline, Pfizer drops oral drug after liver injury case

Exclusive: A small biotech will bring Roche's Angelman drug back to life

Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

Biotech seed rounds sink to lowest level in years as industry slump drags on

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

Ahead of ad­comm for full ap­proval, FDA es­ti­mates Pfiz­er's Covid pill could save 1,500 lives per week

Senior Editor

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

Ahead of adcomm for full approval, FDA estimates Pfizer's Covid pill could save 1,500 lives per week